retatrutide phase 3 trial dosing schedule Reta clinical data & — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in trials for metabolic health — targeting GLP-1, GIP Retatrutide Dosage Guide 2026: Phase

However, starting in July 2026, a new program called the BALANCE Model may give eligible Medicare Part D beneficiaries access to certain GLP-1 weight loss medications for a $50 copay

The World Health Organization has acknowledged lower BMI cutoffs for Asian populations

Do I need to tell my surgeon I am taking this

Here's a quick comparison: While dosing schedules appear similar, retatrutide's triple-receptor mechanism (GLP-1 + GIP + glucagon) produces different effects than dual-agonists like tirzepatide or single-agonists like semaglutide

For storage best practices, see our peptide storage guide

Visit our Contrave coupon page for updated Contrave prices near you